July 13, 2022
Medical Research
Fulcrum Phase 3 FSHD Clinical Trial Using AMRA Medical’s Whole-body MRI Measurements as a Key Secondary Endpoint
REACH, a Phase 3 Clinical Trial of losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) utilizes AMRA’s Muscle Fat Infiltration (MFI) as a secondary endpoint. AMRA…